The rise in sEV-MASP2 from BR to TR, while showing a trend, did not reach statistical significance.
← all excerpts
Serial proteomic analysis identifies small extracellular vesicle-MASP2 as an early biomarker of chemotherapy response in advanced pancreatic cancer.
1
—
—